Monsanto/PHC seed treatment deal

摘要

Monsanto has entered into an agreement with UK bioproducts company Plant Health Care's (PHC) US subsidiary over the commercialisation of PHC's harpin-based technology in seed treatments for certain crops. PHC will grant Monsanto an exclusive long-term licence to use the technology in maize, soybeans, cotton, canola and selected vegetables. In December 2007, Monsanto agreed to evaluate the harpin t echnology for the control of nematodes in agricultural crops (Agrow No 534, p 4). PHC will receive the milestone payment agreed under that deal, along with ongoing royalties based on seed treatment volumes. Monsanto agreed to place its first order for harpin by the end of 2008.